2003 - Hon'ble High Court of Bombay approved the Scheme of Amalgamation of company with P I Drugs & Pharmaceuticals Ltd. 2007 -PI Drugs & Pharmaceuticals Ltd has informed that Dr. Gopakumar G Nair has joined the Board as Independent Director effective June 20, 2007. 2008 - PI Drugs Board recommends dividend @ 10% 2009 - PI Drugs & Pharmaceuticals Ltd equity shareholders approve Scheme of Amalgamation - PI Drugs & Pharmaceuticals Ltd Board recommends Dividend@ 10% - PI Drugs & Pharmaceuticals Ltd - Change of name of the Company from PI Drugs & Pharmaceuticals Ltd to Sequent Scientific Ltd. 2010 - SeQuent Scientific to invest Rs. 150 crore in three new therapeutic segments - Signs an MoU with Karnataka Government. 2011 - PI Drugs & Pharmaceuticals Ltd Appoined Mr. Vinayak Hegde as Company Secretary . 2012 - PI Drugs - Issue of Warrants on Preferential basis - PI Drugs - Alloted 10,00,000 fully paid equity shares of Rs. 10/- each --Registered Office of the Company has been shifted from No. 116, Vardhaman Industrial Complex, Lal Bahaddur Shastri Marg, Thane west - 400 601 to 301, 'Dosti Pinnacle', 3rd Floor, Plot No. E7, Road No. 22, Wagle Indl. Estate, Thane (W) - 400 604. 2013 -Sequent receives US FDA Approval for ITS API Drug Manufacturing Facility at Mangalore. -Sequent Scientific Ltd & Shasun Pharmaceuticals Ltd announce Joint Venture to Create Leading Animal Health Company. 2014 -SeQuent Scientific Limited announces completion of Sale of Specialty Chemicals division to Songwon Industrial Group. -Sequent Scientific to acquire the business of Arvee Synthesis Acquisition to provide impetus to Human API business. -Sequent Scientific - Updates - Alivira completes acquisition of majority stake in Provet Veterinary Products AS, Turkey. 2015 -SeQuent Scientific to acquire Animal Health business of Lyka Exports -SeQuent Scientific inaugurates new Analytical Services Centre at Bengaluru 2016 - SeQuent Scientific to acquire controlling stake in Indo Phyto Chemicals Forays into steroids and hormone -Sequent Scientific commences production in Vizag facility 2017 -SeQuent Scientific said that , its arm Alivira has received approval from the US health regulator for its animal health API facility in Visakhapatnam in Andhra Pradesh. 2018 -SeQuent Scientific Limited (SeQuent), has said that its wholly owned subsidiary Alivira Animal Health Limited (“Alivira”) through Alivira Ireland, has signed an agreement with simultaneous closing to acquire 100 per cent of Bremer Pharma, Zydus Cadila’s Animal Health Business in Germany . 2020 -Sequent Scientific announces addition of new state-of-art Animal Health R&D Centre at Mumbai -SeQuent Scientific receives EIR from US FDA for its Analytical Laboratory at Bengaluru 2021 -Sequent Scientific forays into pet segment in Brazil -The company has said that Evance Saude Animal Health Ltda ('Evance'), Brazil, a subsidiary of the Company has entered into a definitive agreement for acquisition of 100% stake in Nourrie Sa£de e Nutri‡ao Animal Ltda ('Nourrie').\r\n\r\nIn this regard, -SeQuent Scientific Limited (SeQuent) has said that European Union Good Manufacturing Practices (EUGMP) approval of its tablets dosage manufacturing line in Turkey. -SeQuent received CEP approval for Diclazuril API